Adjuvant Therapy Clinical Trials in Nanjing, Jiangsu
5 recruitingNanjing, Jiangsu, China
Showing 1–5 of 5 trials
Recruiting
Not Applicable
A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.
Adjuvant TherapyTNBCLymph Node Positive
The First Affiliated Hospital with Nanjing Medical University59 enrolled1 locationNCT07622836
Recruiting
Phase 2
A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Neoadjuvant TherapyLocally Advanced Esophageal Squamous Cell Carcinoma
Sun Jing30 enrolled1 locationNCT06356688
Recruiting
Phase 2
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
Hepatocellular Carcinoma (HCC)Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation
The First Affiliated Hospital with Nanjing Medical University276 enrolled1 locationNCT06762782
Recruiting
Not Applicable
Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
Pancreatic CancerAdjuvant Therapy
Kuirong Jiang53 enrolled1 locationNCT06361316
Recruiting
Phase 2
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
Neoadjuvant TherapyHigh-risk Prostate CancerLocally Advanced Prostate Cancer+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School900 enrolled1 locationNCT05406999